In medical terms, CCP stands for cyclic citrullinated peptide. You’ll most often see it on lab orders as an “anti-CCP antibody test,” which is a blood test used to help diagnose rheumatoid arthritis (RA). CCP antibodies are found in most people with rheumatoid arthritis and are almost never found in people without the disease, making this one of the most reliable markers available for the condition.
What CCP Antibodies Actually Are
CCP antibodies are a type of autoantibody, meaning they’re immune proteins that mistakenly attack your own body instead of foreign invaders like bacteria or viruses. Specifically, CCP antibodies target healthy tissues in the joints.
The “citrullinated peptide” part refers to a chemical change that happens to certain proteins in your body. Normally, an enzyme converts one building block of a protein (arginine) into a slightly different form called citrulline. This process, called citrullination, is a routine part of cell biology. Problems arise when the process goes haywire. If the enzyme becomes overactive, it can modify proteins in unusual ways or at unusual sites, creating altered proteins the immune system has never encountered before. In genetically susceptible people, the immune system treats these modified proteins as threats and produces antibodies against them. Those antibodies are what the anti-CCP test detects.
Why Doctors Order the Anti-CCP Test
The anti-CCP test is primarily used to confirm or rule out rheumatoid arthritis, especially early in the disease when symptoms can overlap with other conditions like lupus, psoriatic arthritis, or osteoarthritis. It’s often ordered alongside another blood test called rheumatoid factor (RF), which has been used for decades. The two tests catch roughly the same percentage of RA cases (around 62 to 69%), but anti-CCP is significantly better at ruling out false alarms.
The key advantage of the anti-CCP test is its specificity: about 95 to 97% of people who don’t have RA will correctly test negative. Rheumatoid factor, by comparison, has a specificity of only 85 to 90%. That means RF produces far more false positives. Conditions like hepatitis C, other autoimmune diseases, and even normal aging can cause a positive RF result without RA being present. A positive anti-CCP result, on the other hand, is much more likely to mean RA is actually the cause of your symptoms. In one large study, the positive predictive value was 79% for anti-CCP compared to just 56% for RF.
Reading Your Results
Anti-CCP results are reported in units (U), and labs typically use the following ranges:
- Below 20 U: Negative
- 20 to 39.9 U: Weak positive
- 40 to 59.9 U: Positive
- 60 U or higher: Strong positive
A negative result doesn’t completely rule out RA, since about one-third of people with rheumatoid arthritis never develop detectable anti-CCP antibodies. But a positive result, particularly a strong positive, makes the diagnosis much more likely. Your doctor will typically combine the anti-CCP result with your symptoms, physical exam, imaging, and other bloodwork to reach a diagnosis.
What Your CCP Level Says About Prognosis
Beyond diagnosis, the level of anti-CCP antibodies in your blood carries important information about how aggressive the disease may become. Research tracking patients over five years found a clear dose-response relationship: the higher the initial anti-CCP level, the greater the risk of erosive joint damage.
Even levels that fall below the standard cutoff for a positive result appear to matter. Patients with a baseline level between just 2 and 5 U/ml were 3.6 times more likely to develop joint erosions within five years compared to those with the lowest levels. At the other end of the spectrum, patients whose levels exceeded four times the upper limit of normal were 10 times more likely to develop significant joint damage. This is one reason doctors pay attention not just to whether the test is positive, but to how high the number is. A strongly positive result often signals that earlier or more aggressive treatment could help preserve joint function.
How Anti-CCP Differs From Rheumatoid Factor
Rheumatoid factor was the standard RA blood test for decades, and it remains useful, but anti-CCP has become the more informative marker in several ways. Both tests pick up a similar proportion of RA cases, so neither is clearly better at detecting the disease. The difference is in what happens when someone tests positive who doesn’t actually have RA.
RF is positive in roughly 10 to 15% of healthy people, especially older adults, and it shows up in a range of other conditions. Anti-CCP is far more specific to RA. When the two tests are combined, the diagnostic picture becomes much clearer. A patient who is positive on both tests has a very high probability of having RA. A patient who is positive on anti-CCP alone still has strong evidence pointing toward RA. A patient who is positive on RF alone warrants more investigation, since that result could stem from another cause entirely.
Anti-CCP also appears to be a better predictor of which patients will develop the bone erosions and joint destruction that make RA a progressive, disabling disease. Multiple studies have confirmed that anti-CCP positivity is more strongly linked to radiographic progression than RF positivity.
What the Test Involves
The anti-CCP test is a standard blood draw, no different from any routine lab work. No fasting or special preparation is required. Results typically come back within a few days, depending on the lab. The test can be run at any point during the diagnostic process, but it’s especially valuable early on, when joint symptoms are new and the cause is still uncertain. Catching RA early gives you the best chance of starting treatment before permanent joint damage occurs.